SARS-CoV-2aptamers

Minghui Yang1, Chunhui Li1, Guoguo Ye2

  • 1School of Life Science, Advanced Research Institute of Multidisciplinary Science, Key Laboratory of Molecular Medicine and Biotherapy, Beijing Institute of Technology, Beijing, 100081, China.

概括

研究人员开发了针对多种人类冠状病毒 (HCoV) 的核囊蛋白的广谱ssDNA吸收体. 这些体对SARS-CoV-2具有强烈的抗病毒活性,包括Omicron变种,为应对新出现的冠状病毒威胁提供了有前途的战略.